Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)

YTD

ALL

Why Robinhood?

You can watch AST+ and buy or sell other stocks, ETFs, and their options commission-free!

About AST+

Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases.

CEO

Brian M. Culley, MBA

CEOBrian M. Culley, MBA

Employees

—

Employees—

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

2012

Founded2012

Employees

—

Employees—

AST+ Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

The current Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)(AST+) stock price is $0.95.

Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)(AST+) stock opened on 2025-12-11 at —. The price climbed to — and dipped to —.

Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)(AST+) shares are trading with a volume of 0.